
Telro AH 40mg/5mg/12.5mg Tablet
Marketer
Med Lex Pharmaceutical
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telro AH 40mg/5mg/12.5mg Tablet
Tri-Med HP 40mg/5mg/12.5mg tablets combine multiple agents to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, thereby mitigating the risk of future cardiovascular events such as stroke and heart attack. Tri-Med HP may be ingested with or without food; dosage is individualized based on patient response and condition, ideally at the same time daily. Continuous use, as directed by your physician, is crucial; discontinuation increases stroke and heart attack risk. The medication includes a diuretic, prompting increased urination, so avoid administration within four hours of bedtime. Regular use, even during asymptomatic periods, maximizes therapeutic benefits. Common side effects include headache, fatigue, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinusitis. Report persistent, worsening, or bothersome side effects to your doctor. Adequate hydration is recommended to counteract potential side effects such as dry mouth, thirst, and muscle weakness. Prior to commencing therapy, inform your physician of any existing liver or kidney ailments. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Disclose all current medications, especially those for hypertension or cardiac conditions. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to ensure optimal therapeutic efficacy.
Primary Ingredients of Telro AH 40mg/5mg/12.5mg Tablet
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Telro AH 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telro AH 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telro AH 40mg/5mg/12.5mg tablet whole; do not chew, crush, or divide it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of Telro AH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telro AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 40mg/5mg/12.5mg Telro AH tablet whole; avoid chewing, crushing, or fracturing it. While consumption with or without food is permissible, consistent daily timing is recommended for optimal results.
How Telro AH 40mg/5mg/12.5mg Tablet works:
Each Telro AH 40mg/5mg/12.5mg tablet combines telmisartan, an angiotensin receptor blocker (ARB); amlodipine, a calcium channel blocker (CCB); and hydrochlorothiazide, a diuretic. Telmisartan and amlodipine reduce blood pressure by promoting vasodilation, widening and relaxing blood vessels. Hydrochlorothiazide lowers blood pressure by increasing urine output, eliminating excess fluid and electrolytes, and contributing to long-term vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telro AH 40mg/5mg/12.5mg Tablet with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Telro AH 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical counsel.
Breast feedingUNSAFE
The combination medication Telro AH 40mg/5mg/12.5mg tablets should not be taken while breastfeeding due to the potential for infant harm from the drug's toxic effects.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telro AH 40mg/5mg/12.5mg Tablets, including dizziness, headache, nausea, or fatigue, which can reduce concentration.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telro AH 40mg/5mg/12.5mg tablets, as dosage modification may be necessary. Medical advice is recommended. Telro AH 40mg/5mg/12.5mg tablets are not advised for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Telro AH 40mg/5mg/12.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telro AH 40mg/5mg/12.5mg Tablet :
Should you forget to take a Telro AH 40mg/5mg/12.5mg Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Telro AH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
